Article
A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.
Future oncology (London, England) - 1 Mar 2014
Li Guangliang, Teng Lisong
Abstract excerpt
A major challenge in cancer therapy lies in its complexity and heterogeneity, with increasing recognition of many tumor subtypes that have different biological characteristics and responses to therapies. To effectively address this challenge, personalized medicine has been the 'vogue' currently. Dissecting the detailed clonal architecture of cancer by cancer genomics, which holds the promise of personalized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
